|1.||Kemona, Halina: 4 articles (08/2005 - 01/2002)|
|2.||Kasperska-Zajac, Alicja: 3 articles (01/2010 - 07/2005)|
|3.||Dymicka-Piekarska, Violetta: 3 articles (08/2005 - 06/2003)|
|4.||Lip, Gregory Y H: 3 articles (01/2005 - 05/2002)|
|5.||Blann, Andrew D: 3 articles (01/2005 - 05/2002)|
|6.||Yamamoto, T: 3 articles (11/2002 - 01/2000)|
|7.||Bodzenta-Lukaszyk, A: 2 articles (01/2009 - 03/2005)|
|8.||Rogala, Barbara: 2 articles (05/2007 - 07/2005)|
|9.||Schroyens, Wilfried: 2 articles (12/2006 - 09/2006)|
|10.||Berneman, Zwi: 2 articles (12/2006 - 09/2006)|
|1.||Myocardial Ischemia (Ischemic Heart Diseases)
09/01/1981 - "Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo."
01/01/1982 - "Beta-thromboglobulin (beta TG) plasma levels were measured by radioimmunoassay in 14 patients with acute myocardial infarction (MI), in 13 with myocardial ischemia and recurrent episodes of angina and in 14 subjects with a past history of MI. "
12/01/1981 - "In view of the tendency toward vascular complications in diabetes mellitus, we studied platelet aggregation and plasma beta-thromboglobulin (beta-TG) levels in 35 healthy controls, 25 non-diabetic patients with ischemic heart disease (IHD) and 85 diabetic patients. "
07/01/1982 - "Studies of platelet factor 4 and beta thromboglobulin release during exercise: lack of relationship to myocardial ischemia."
08/15/1997 - "Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease."
05/01/1988 - "[Thrombocyte aggregation, levels of thrombocyte factor 4 and beta-thromboglobulin in the blood plasma of patients with unstable stenocardia and acute myocardial infarct]."
01/01/1984 - "The plasma beta thromboglobulin concentration predicted more accurately the extent of the coronary artery disease than the functional angina pectoris classification. "
01/01/1984 - "Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction."
07/01/1985 - "Fibrinopeptide A (FpA) concentrations in plasma and in 24 hr urine specimens as well as beta-thromboglobulin (BTG) in plasma were measured in 17 patients with severe angina pectoris, including both stable and unstable angina, and in 19 patients with acute myocardial infarction. "
01/01/1984 - "The purpose of this study was to investigate the degree of platelet activation and thrombin generation in 40 patients with stable angina pectoris and in 20 patients with acute myocardial infarction (AMI) by determining the plasma beta thromboglobulin (BTG) and fibrinopeptide A (FPA) concentrations. "
01/15/1985 - "Plasma beta-thromboglobulin is correlated with platelet adhesiveness to bovine endothelium in patients with diabetes mellitus."
10/01/1984 - "A chronic overstimulation of platelets could be responsible for the high basal plasma beta-thromboglobulin concentration in diabetes mellitus and for its abnormal behaviour after physical exercise."
10/01/1984 - "Plasma beta-thromboglobulin concentration at rest and after physical exercise in complicated and uncomplicated diabetes mellitus."
09/30/1983 - "[Levels of beta-thromboglobulin in type I diabetes mellitus. "
12/01/1981 - "Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus."
|4.||Primary Myelofibrosis (Myelosclerosis)
01/01/1982 - "After therapy-induced remission, the number of marrow megakaryocytes decreased, the alpha-granules were normally produced, the plasma beta-thromboglobulin level was normal and the myelofibrosis disappeared. "
01/01/1987 - "To investigate the platelet contribution to the development of myelofibrosis in hairy cell leukaemia (HCL), we have studied two platelet alpha granule components in 15 patients with HCL before chemotherapy: mitogenic activity was measured by 3H thymidine incorporation in BALB/C 3T3 cells and beta thromboglobulin (beta TG) assayed by radioimmunoassay (RIA). "
06/02/1990 - "[Beta-thromboglobulin and platelet factor 4 in a follow-up of acute myelofibrosis (megakaryoblastic leukemia)]."
06/02/1990 - "It is now known that this megakaryoblastic proliferation is responsible for myelofibrosis as an increased release of platelet-derived growth factor (PDGF), beta-thromboglobulin (BTG), and platelet factor 4 (PF4) develops because ineffective megakaryocytopoiesis and failure of these clonal populations to store the mentioned substances in their alpha granules. "
10/01/1995 - "Although the exact mechanism for the progression of myelofibrosis in acute megakaryoblastic leukaemia is unclear, certain humoral factors released from the proliferating megakaryoblasts that are unable to store these factors in their defective alpha-granules, including platelet derived growth factor (PDGF), fibroblast growth factors (FGF), platelet factor-4 (PF-4), transforming growth factor-beta (TGF-beta) and beta-thromboglobulin, could result in increased collagen synthesis by bone marrow fibroblasts. "
10/28/1987 - "The range and the mean of plasma TSP concentrations of patients with vasculitis were 117 ng/ml to 6500 ng/ml and 791 +/- 1412 ng/ml (mean +/- SD); the range and the mean of plasma TSP concentrations of control individuals (n = 33) were 13 ng/ml to 137 ng/ml and 59 +/- 29 ng/ml. When plasma TSP concentrations were correlated with plasma concentrations of another platelet activation marker, beta-thromboglobulin (beta-TG), it was found that the TSP concentration increased exponentially as the plasma beta-TG level rose. "
11/01/2002 - "Elevated plasma levels of beta-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis."
06/01/1981 - "Four patients with intravascular platelet consumption (three with thrombotic thrombocytopenic purpura and one with vasculitis) had significantly higher plasma beta-thromboglobulin levels than four patients with extravascular platelet destruction due to idiopathic thrombocytopenic purpura. "
11/01/2002 - "The efficacy of plasma levels of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) as markers of the presence and activity of vasculiditic processes in rheumatic diseases were evaluated, first by serial measurement of their levels in a patient with rheumatoid arthritis and a chronic leg ulcer in the course of treatment, and second in 11 patients with rheumatoid arthritis without cutaneous vasculitis, and in nine patients with a variety of rheumatic diseases with cutaneous vasculitis. "
|1.||Platelet Factor 4
|3.||Fibrinogen (Factor I)
|4.||fibrin fragment D (D-dimer)
|6.||Tissue Plasminogen Activator (Alteplase)
|7.||Factor VII (Proconvertin)
|2.||Intensive Care (Surgical Intensive Care)
|3.||Renal Dialysis (Hemodialysis)
|4.||Drug Therapy (Chemotherapy)
|5.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)